Dr. Judy Chang and her team examined the prevalence or correlations of cannabidiol (CBD) use among pregnant people under the age of 22.
Read the study here: https://pubmed.ncbi.nlm.nih.gov/36717004/
![Descriptive survey data from the Pregnancy-Unique Quantification of Emesis (PUQE) tool for the total PUQE score (A) and components of PUQE score (hours of nausea [B], episodes of vomiting [C], and episodes of dry heaves [D]) among those with and without detectable urine 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH). The PUQE score evaluates symptoms over the previous 12 hours. E. Logistic regression model results for the association between THC-COOH and the primary outcome.](/sites/default/files/styles/medium/public/2023-01/Screenshot%202023-01-06%20at%2011.39.49%20AM.png?itok=YwXtTzUT)
Dr. Jarlenski and her team evaluated whether cannabis use was associated with nausea and vomiting in early pregnancy, and found that higher THC levels were associated with increased odds of moderate-to-severe nausea (20.7% THC detected vs 15.5% in THC not detected).
Breast/chestfeeding is beneficial for infants and parents, and stigmatization of substance use in pregnancy has been historically linked to punitive approaches with a disproportionate impact on minority populations. Dr. Marielle Gross advanced an empirically informed ethical analysis of this issue based on the current U.S. guidelines.
Read more: https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00127-y
Dr. Marian Jarlenski and PhD candidate Noelle Spencer reviewed the perceived safety of cannabis, nicotine, and tobacco use among US women of reproductive age.
Read more about this study here: https://oce-ovid-com.pitt.idm.oclc.org/article/00003081-202206000-00014/HTML
